| Title | Author(s) | Year | View Count |
 | No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. | Sawai, H; Nishida, N; Mbarek, H; Matsuda, K; Mawatari, Y; Yamaoka, M; Hige, S; Kang, JH; Abe, K; Mochida, S; Watanabe, M; Kurosaki, M; Asahina, Y; Izumi, N; Honda, M; Kaneko, S; Tanaka, E; Matsuura, K; Itoh, Y; Mita, E; Korenaga, M; Hno, K; Murawaki, Y; Hiasa, Y; Ide, T; Ito, K; Sugiyama, M; Ahn, SH; Han, KH; Park, JY; Yuen, RMF; Nakamura, Y; Tanaka, Y; Mizokami, M; Mizokami, M; Tokunaga, K | 2012 | 60 |
 | A phase IIb study of the efficacy and safety of LB80380 vs entecavir in treatment-naive patients with chronic hepatitis B | Lai, CL; Ahn, SH; Lee, KS; Um, SH; Cho, M; Yoon, SK; Lee, JW; Park, NW; Kwon, YO; Sohn, JH; Lee, JY; Park, HE; Kim, JA; Han, KH; Yuen, MF | 2011 | 206 |
| Asian consensus workshop report: Expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia | Han, KH; Kudo, M; Ye, SL; Choi, JY; Poon, RTP; Seong, J; Park, JW; Ichida, T; Chung, JW; Chow, P; Cheng, AL | 2011 | 72 |
| Week 48 analysis of a Phase IIB study of the efficacy and safety of LB80380 vs. entecavir in treatment-naive patients with chronic Hepatitis B | Lai, CL; Ahh, SH; Lee, KS; Um, SH; Cho, M; Yoon, SK; Lee, JW; Park, NH; Kweon, YO; Sohn, JH; Lee, J; Kim, JA; Han, KH; Yuen, MF | 2011 | 52 |
| Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive score | Yang, HI; Yuen, MF; Chan, HLY; Han, KH; Chen, PJ; Kim, DY; Ahn, SH; Chen, CJ; Wong, VWS; Seto, WK | 2011 | 999 |
| Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma | Omata, M; Lesmana, LA; Tateishi, R; Chen, PJ; Lin, SM; Yoshida, H; Kudo, M; Lee, JM; Choi, BI; Poon, RTP; Shiina, S; Cheng, AL; Jia, JD; Obi, S; Han, KH; Jafri, W; Chow, P; Lim, SG; Chawla, YK; Budihusodo, U; Gani, RA; Lesmana, CR; Putranto, TA; Liaw, YF; Sarin, SK | 2010 | 58 |
| Liver cancer working group report | Kudo, M; Han, KH; Kokudo, N; Cheng, AL; Choi, BI; Furuse, J; Izumi, N; Park, JW; Poon, RT; Sakamoto, M | 2010 | 316 |
| Antiviral activity and safety of LB80380 in hepatitis B e antigen-positive chronic hepatitis B patients with lamivudine-resistant disease | Yuen, MF; Han, KH; Um, SH; Yoon, SK; Kim, HR; Kim, J; Kim, CR; Lai, CL | 2010 | 59 |
| Efficacy of entecavir in chronic hepatitis b patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage | Wu, IC; Lai, CL; Bui Han, SH; Han, KH; Gordon, SC; Chao, YC; Tan, CK; Sievert, W; Tanwandee, T; Xu, D; Neo, BL; Chang, TT | 2010 | 48 |
| Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B | Chang, TT; Liaw, YF; Wu, SS; Schiff, E; Han, KH; Lai, CL; Safadi, R; Lee, SS; Halota, W; Goodman, Z; Chi, YC; Zhang, H; Hindes, R; Iloeje, U; Beebe, S; Kreter, B | 2010 | 80 |
 | Asia-Pacific Working Party on Prevention of Hepatocellular Carcina. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region. | Amarapurkar, D; Han, KH; Chan, HL; Ueno, Y; Yuen, RMF | 2009 | 301 |
| Errata: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update | Liaw, YF; Leung, N; Kao, JH; Piratvisuth, T; Gane, E; Han, KH; Guan, R; Lau, GKK; Locarnini, S; The Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver | 2008 | 122 |
| Efficacy of entecavir in nucleoside-naefve patients with mildly elevated ALT | Gordon, SC; Han, SH; Chang, TT; Lai, CL; Han, KH; Chao, YC; Tan, CK; Sievert, W; Tanwandee, T; Neo, BL | 2008 | 98 |
| Long-term entecavir therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in patients with HBeAg(+) and (-) chronic hepatitis B: results from studies ETV-022, -027 and -901. | Liaw, YF; Chang, TT; Wu, SS; Schiff, ER; Han, KH; Lai, CL; Safadi, R; Lee, SS; Halota, W; Goodman, ZD; Zhang, H; Hindes, R; Hoeje, U; Beebe, S; Kreter, B | 2008 | 193 |
| Phase II multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV | Lai, CL; Han, KH; Yoon, SK; Um, SH; Yuen, MF; Kim, HS; Kim, HR; Chung, HC; Kim, CR; Hsyu, P; Averett, D; Worland, S; Kim, J | 2006 | 199 |
| Role of nicotinic acid in raising high-density lipoprotein cholesterol (HDL-C) to reduce cardiovascular risk: An Asian/Pacific consensus | Barter, PJ; O'Brien, R; Watts, GF; Zhu, J; Hu, D; Ho, CC; Tomlinson, B; Cheung, BMY; Adam, JMF; Tjokroprawiro, A; Waspadji, S; Cho, HK; Han, KH; Kim, SR; Lin, KK; Chan, SP; Basit, A; PizzaroBorromeo, AB; PazPacheco, E; Sy, RG; Lee, KO; Low, LP; Khue, NT; Binh, TV | 2005 | 115 |
|
